Arthur Morgan, who has spinal muscular atrophy (SMA), received the one-off US gene therapy, Zolgensma, last week. A five-month-old baby with a spinal disorder has become the first NHS patient in England to be treated with a potentially life-saving drug that can prolong life.
Read More »